SecurityTRVG / Trivago NV (89686D105)
Institutional Owners65
Institutional Shares27,622,788
Institutional Value$ 268,349,000 USD

Institutional Stock Ownership and Shareholders()

TRVG / Trivago NV Institutional Ownership

Trivago NV (NASDAQ:TRVG) has 65 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,622,788 shares. Largest shareholders include Price T Rowe Associates Inc /md/, 683 Capital Management, LLC, Cadian Capital Management, Lp, Altrinsic Global Advisors Llc, Deutsche Bank Ag\, Steadfast Capital Management Lp, Par Capital Management Inc, Altimeter Capital Management, LP, Apertura Capital, LLC, and Ameriprise Financial Inc.
Trivago NV (NASDAQ:TRVG) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/trvg"><img src="https://images.fintel.io/us-trvg-so.png" alt="TRVG / Trivago NV Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-20 13F-HR FIRST MANHATTAN CO 800 250 -68.75 5 1 -80.00
2018-05-11 13F-HR TD ASSET MANAGEMENT INC 108,472 108,472 0.00 742 754 1.62
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 351,900 156,100 -55.64 2,407 1,085 -54.92
2018-05-14 13F-HR GRANAHAN INVESTMENT MANAGEMENT INC/MA 297,457 75,718 -74.54 2,035 526 -74.15
2018-05-11 13F-HR CITADEL ADVISORS LLC 329,438 2,290
2017-02-14 13F-HR STEADFAST ADVISORS LP 45,102 530
2018-05-14 13F-HR Pacad Investment Ltd. 0 8,500 0 57
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 26,800 46,100 72.01 183 320 74.86
2018-04-10 13F-HR Gradient Investments LLC 10 10 0.00 0 0
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 819,700 155,500 -81.03 5,607 1,081 -80.72
2018-05-15 13F-HR Advisor Group, Inc. 1,500 1,500 0.00 10 10 0.00
2018-05-15 13F-HR UBS Group AG 6,257 6,569 4.99 43 46 6.98
2018-05-14 13F-HR PROFUND ADVISORS LLC 139,000 76,750 -44.78 951 533 -43.95
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 37,600 23,800 -36.70 257 165 -35.80
2018-05-15 13F-HR DEUTSCHE BANK AG\ 1,927,540 2,418,070 25.45 13,183 16,804 27.47
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 40,856 109,373 167.70 279 760 172.40
2018-05-15 13F-HR PEAK6 Investments, L.P. Put 10,500 0 -100.00 72 0 -100.00
2018-05-14 13F-HR Virtu Financial LLC 51,154 356
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 84,500 586,221 593.75 578 4,075 605.02
2018-05-11 13F-HR Cutler Group LP Call 15,900 19,400 22.01 0 1
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,000 15,000 0.00 103 104 0.97
2018-05-08 13F-HR Penserra Capital Management LLC 277,831 413,418 48.80 1,900 2,873 51.21
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 157,079 0 -100.00 1,074 0 -100.00
2018-04-17 13F-HR Calton & Associates, Inc. 200 0 -100.00 1 0 -100.00
2018-02-08 13F-HR GIRARD SECURITIES, INC. 14,000 0 -100.00 155 0 -100.00
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ Put 141,300 191,300 35.39 966 1,330 37.68
2018-05-15 13F-HR PAR CAPITAL MANAGEMENT INC 750,000 1,135,976 51.46 5,130 7,895 53.90
2018-04-18 13F-HR Sonora Investment Management, LLC 950 950 0.00 6,498 6,603 1.62
2018-05-09 13F-HR NORTHERN TRUST CORP 37,900 0 -100.00 259 0 -100.00
2018-05-15 13F-HR WOLVERINE TRADING, LLC 31,918 16,615 -47.94 218 115 -47.25
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 737 90 -87.79 70 6 -91.43
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 7,700 7,700 0.00 53 54 1.89
2018-05-15 13F-HR DEUTSCHE BANK AG\ Call 1,285 0 -100.00 8 0 -100.00
2018-05-14 13F-HR Oz Management LP 71,900 48,900 -31.99 492 340 -30.89
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 112,700 149,400 32.56 771 1,038 34.63
2018-02-14 13F-HR DELTA PARTNERS LLC 67,829 0 -100.00 736 0 -100.00
2018-05-14 13F-HR Wealthcare Advisory Partners LLC 24 24 0.00 0 0
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC Call 100,000 0 -100.00 684 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 0 1,250 0 9
2018-05-11 13F-HR LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 342,335 0 -100.00 2,342 0 -100.00
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 87,483 0 -100.00 598 0 -100.00
2018-05-15 13F-HR PEAK6 Investments, L.P. 554 0 -100.00 4 0 -100.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 448,882 297,932 -33.63 3,071 2,070 -32.60
2018-05-15 13F-HR Walleye Trading LLC 35,325 0 -100.00 242 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 1,205,743 421,955 -65.00 8,247 2,933 -64.44
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 0 30,000 0 209
2018-05-15 13F-HR 683 Capital Management, LLC Put 300,000 0 -100.00 2,052 0 -100.00
2018-05-15 13F-HR Point72 Asia (Hong Kong) Ltd 110 0 -100.00 1 0 -100.00
2018-05-11 13F-HR Apertura Capital, LLC 785,946 5,462
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 334,500 35,800 -89.30 2,288 249 -89.12
2018-05-03 13F-HR Trexquant Investment LP 77,295 0 -100.00 529 0 -100.00
2017-07-06 13F-HR Independent Portfolio Consultants, Inc. 8,020 190
2018-06-14 13F-HR/A Dynamic Technology Lab Private Ltd 61,653 428
2018-05-15 13F-HR Greenhouse Funds LLLP 163,816 1,139
2018-05-15 13F-HR STATE STREET CORP 30,473 27,303 -10.40 208 190 -8.65
2018-05-01 13F-HR AMERICAN NATIONAL INSURANCE CO /TX/ 36,500 36,500 0.00 250 254 1.60
2018-05-09 13F-HR BlackRock Inc. 28,729 4,554 -84.15 197 32 -83.76
2018-05-15 13F-HR Point72 Asset Management, L.P. 250,000 0 -100.00 1,710 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 12,017 0 -100.00 82 0 -100.00
2017-05-16 13F-HR JANUS CAPITAL MANAGEMENT LLC 300,000 0 -100.00 3,525 0 -100.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 325,840 505,710 55.20 2,229 3,515 57.69
2018-05-14 13F-HR CADIAN CAPITAL MANAGEMENT, LP 2,990,427 2,990,427 0.00 20,455 20,783 1.60
2018-05-15 13F-HR Walleye Trading LLC Put 104,600 0 -100.00 715 0 -100.00
2017-11-15 13F-HR INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 63,808 0 -100.00 1,510 0 -100.00
2018-05-11 13F-HR ALTRINSIC GLOBAL ADVISORS LLC 2,544,211 2,486,526 -2.27 17,402 17,281 -0.70
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC Call 2,500 17
2018-05-11 13F-HR CITADEL ADVISORS LLC Call 23,800 165
2018-05-15 13F-HR JANE STREET GROUP, LLC 15,541 108
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 1,400 400 -71.43 18 2 -88.89
2018-05-15 13F-HR CREDIT SUISSE AG/ 91,144 38,961 -57.25 623 271 -56.50
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC Call 155,600 0 -100.00 1,064 0 -100.00
2018-05-11 13F-HR Cutler Group LP 16,421 2,348 -85.70 112 16 -85.71
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 59 1 -98.31 0 0
2018-04-19 13F-HR Janney Montgomery Scott LLC 11,700 0 -100.00 80 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 657,699 0 -100.00 4,499 0 -100.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 21,900 79,100 261.19 150 550 266.67
2018-05-02 13F-HR Global X Management CO LLC 3,574 4,594 28.54 24 32 33.33
2018-05-14 13F-HR Oz Management LP Put 71,900 48,900 -31.99 492 340 -30.89
2018-05-02 13F-HR Trellus Management Company, LLC 200,000 1,390
2018-05-15 13F-HR Marshall Wace North America L.P. 0 16,716 0 116
2018-05-08 13F-HR US BANCORP \DE\ 8,828 5,212 -40.96 61 36 -40.98
2018-05-15 13F-HR A.R.T. Advisors, LLC 64,662 0 -100.00 442 0 -100.00
2018-05-15 13F-HR Squarepoint Ops LLC 50,172 0 -100.00 343 0 -100.00
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 85,400 45,900 -46.25 584 319 -45.38
2018-05-14 13F-HR BROWN BROTHERS HARRIMAN & CO 700 5
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 6,000 0 -100.00 41 0 -100.00
2018-04-17 13F-HR Atlas Capital Advisors Llc 10,000 69,500
2018-05-11 13F-HR CITIGROUP INC 108,456 496,125 357.44 742 3,448 364.69
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 553,815 0 -100.00 3,788 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC 64,381 16,222 -74.80 440 112 -74.55
2018-01-24 13F-HR MIK CAPITAL LLC 832,214 0 -100.00 9,030 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 35,800 249
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 263,600 69,770 -73.53 1,803 485 -73.10
2018-05-15 13F-HR Walleye Trading LLC Call 2,400 0 -100.00 16 0 -100.00
2018-05-15 13F-HR Altimeter Capital Management, LP 410,362 1,128,857 175.09 2,807 7,846 179.52
2017-07-20 13F-HR MANNING & NAPIER ADVISORS LLC 266,750 0 -100.00 3,474 0 -100.00
2018-05-15 13F-HR STEADFAST CAPITAL MANAGEMENT LP 0 1,887,932 0 13,121
2018-05-11 13F-HR Russell Investments Group, Ltd. 174,008 18,346 -89.46 1,209 125 -89.66
2018-05-11 13F-HR Cutler Group LP Put 17,200 2,500 -85.47 14 2 -85.71
2018-05-15 13F-HR 683 Capital Management, LLC 2,319,208 4,000,000 72.47 15,863 27,800 75.25
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 141,625 191,625 35.30 968 1,332 37.60
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 870,639 329,438 -62.16 5,955 2,290 -61.54
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 6,304,278 5,633,861 -10.63 43,121 39,155 -9.20
2018-05-02 13F-HR THOMPSON DAVIS & CO., INC. 0 250 0 2
2018-05-10 13F-HR JP Morgan Chase & Co 0 71,951 0 500
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ Call 300 0 -100.00 2 0 -100.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 329,700 0 -100.00 2,255 0 -100.00
2018-05-11 13F-HR Quantbot Technologies LP 8,572 1,400 -83.67 58 9 -84.48
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 936 0 -100.00 6 0 -100.00
2018-05-03 13F-HR Hodges Capital Management Inc. 30,000 40,000 33.33 205 278 35.61
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 742 2,987 302.56 5 21 320.00
2018-05-04 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 3,500 6,150 75.71 24 43 79.17

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

9h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

9h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

10 Best Stocks Under $10

2018-06-19 investorplace
Good things come in small packages goes the saying. Nowhere is that truer than in the markets where stocks under $10 grow to be $100 and possibly even $1,000 over time. (132-1)

Despegar Remains Expensive After The Recent Selloff

2018-06-18 seekingalpha
Brand recognition and partnership with prominent Latin American firms should provide DESP with an edge in the online travel market. (12-0)

SA Interview: Focusing On The Numbers, Not Just The Story, With Peter Kaye

2018-06-17 seekingalpha
What investors miss by focusing only on the qualitative side of a thesis, how to determine what is priced in and how a SaaS business is like a bond are topics discussed. (113-0)

Booking Holdings: Buy On The Dip

2018-05-20 seekingalpha
Booking Holdings, the parent company of Priceline, has reported strong Q1 earnings that beat analyst expectations on both the top and bottom line. (4-0)

Trivago: A Dire Situation

2018-04-26 seekingalpha
Trivago sank to all-time lows after reporting Q1 earnings, in which the company's revenues actually showed a y/y decline.

CUSIP: 89686D105